The mounting impact of weight loss drugs on consumer stocks


Semaglutide pen

Douglas Cliff

In recent weeks, weight loss drugs have made headlines as a result of some companies saying that they could already be having an impact on the bottom line. While at first glance the impact of these medications — known as GLP-1 agonists — might

Source link

Leave A Reply

Your email address will not be published.